9258 Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $316K | Buy |
3,772
+128
| +4% | +$10.7K | 0.05% | 269 |
|
|
2024
Q2 | $250K | Sell |
3,644
-386
| -10% | -$26.5K | 0.04% | 289 |
|
|
2024
Q1 | $295K | Sell |
4,030
-2,340
| -37% | -$171K | 0.05% | 272 |
|
|
2023
Q4 | $516K | Sell |
6,370
-44
| -0.7% | -$3.56K | 0.09% | 180 |
|
|
2023
Q3 | $481K | Buy |
6,414
+16
| +0.3% | +$1.2K | 0.09% | 180 |
|
|
2023
Q2 | $493K | Sell |
6,398
-17
| -0.3% | -$1.31K | 0.09% | 185 |
|
|
2023
Q1 | $532K | Buy |
6,415
+17
| +0.3% | +$1.41K | 0.11% | 169 |
|
|
2022
Q4 | $549K | Buy |
6,398
+1,417
| +28% | +$122K | 0.12% | 162 |
|
|
2022
Q3 | $307K | Hold |
4,981
| – | – | 0.08% | 236 |
|
|
2022
Q2 | $308K | Buy |
4,981
+415
| +9% | +$25.7K | 0.08% | 243 |
|
|
2022
Q1 | $271K | Buy |
4,566
+1
| +0% | +$59 | 0.06% | 298 |
|
|
2021
Q4 | $332K | Buy |
4,565
+110
| +2% | +$8K | 0.08% | 266 |
|
|
2021
Q3 | $311K | Sell |
4,455
-430
| -9% | -$30K | 0.08% | 252 |
|
|
2021
Q2 | $336K | Buy |
4,885
+522
| +12% | +$35.9K | 0.09% | 238 |
|
|
2021
Q1 | $282K | Sell |
4,363
-114
| -3% | -$7.37K | 0.08% | 256 |
|
|
2020
Q4 | $261K | Sell |
4,477
-3,273
| -42% | -$191K | 0.09% | 253 |
|
|
2020
Q3 | $451K | Buy |
7,750
+304
| +4% | +$17.7K | 0.17% | 147 |
|
|
2020
Q2 | $573K | Sell |
7,446
-123
| -2% | -$9.47K | 0.23% | 119 |
|
|
2020
Q1 | $605K | Sell |
7,569
-834
| -10% | -$66.7K | 0.27% | 105 |
|
|
2019
Q4 | $546K | Buy |
8,403
+1,701
| +25% | +$111K | 0.2% | 136 |
|
|
2019
Q3 | $425K | Buy |
6,702
+850
| +15% | +$53.9K | 0.33% | 107 |
|
|
2019
Q2 | $395K | Buy |
5,852
+386
| +7% | +$26.1K | 0.32% | 108 |
|
|
2019
Q1 | $355K | Buy |
5,466
+1,134
| +26% | +$73.7K | 0.3% | 108 |
|
|
2018
Q4 | $271K | Buy |
+4,332
| New | +$271K | 0.26% | 120 |
|